|
|
|
|
Lieff
Cabraser's Privacy Policy
|
| |
| Lieff
Cabraser Heimann & Bernstein, LLP maintains the privacy
of your message. We do not sell your personal information
or e-mail addresses in any manner. We do not post any “cookies”
or other identifiers on the computers of visitors to our
site. |
| If
you choose to contact us via e-mail by completing one of
the contact forms on our website, your message is automatically
forwarded to a Lieff Cabraser attorney and/or legal assistant.
We also retain the information you provide us in a database,
including your first and last name, home address, e-mail
address and telephone number. Again, none of this information
is sold or shared with any outside third party. In certain
cases we may permit co-counsel or retained experts or physicians
to assist our attorneys in reviewing e-mail correspondence
provided that they, in turn, maintain the confidentiality
of your message. |
| With
your consent, we use your e-mail address to send a free
Consumer Law Newsletter. The newsletter is transmitted four
times a year and contains information on consumer safety
issues, updates on cases of widespread public interest and
notices of class action settlements and monies available
to class members. |
| If
you should wish to update or change any personal information
you provided to us, please send an e-mail message to mail
with your new or updated information. We do not permit the
deletion from our databases of any personal information
sent to us via e-mail. If you are already on our newsletter
mailing list and would prefer not to receive such mailings,
please send us a message requesting removal from the list
by sending a message to nolist.
|
| Any
changes to Lieff Cabraser’s privacy policy will be noted
on this page. |
| Effective
Date: September 24, 2004 |
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
Copyright
© 2004-2005 Lieff Cabraser Heimann & Bernstein,
LLP
|
|
|
|
|
"Banned
Report on Vioxx Published" Los Angeles
Times, Jan. 25, 2005
A report on Vioxx risks previously blocked by
the FDA was published online Monday after the
agency withdrew its opposition. The study found
that as many as 140,000 cases of heart disease
in the United States and as many as 56,000 deaths
were caused by the painkiller Vioxx during the
five years that it was on the market.
To read more press articles on the Vioxx recall
and Vioxx class action lawsuit, click
here. |
|
|
|
|